Northern Trust’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-151,944
Closed -$6.97M 4346
2015
Q1
$6.97M Buy
151,944
+572
+0.4% +$17.1K ﹤0.01% 2293
2014
Q4
$3.63M Sell
151,372
-29,316
-16% -$661K ﹤0.01% 2700
2014
Q3
$4.56M Buy
180,688
+65,970
+58% +$1.64M ﹤0.01% 2564
2014
Q2
$2.99M Sell
114,718
-16,707
-13% -$429K ﹤0.01% 2844
2014
Q1
$3.39M Buy
131,425
+15,462
+13% +$419K ﹤0.01% 2810
2013
Q4
$2.34M Buy
115,963
+576
+0.5% +$13.6K ﹤0.01% 3052
2013
Q3
$3.02M Buy
115,387
+31,570
+38% +$791K ﹤0.01% 2837
2013
Q2
$1.84M Buy
+83,817
New +$1.84M ﹤0.01% 3033

Northern Trust's HPTX Position: Q2 2015 in Review

Northern Trust sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 151,944 shares — an estimated $6.97M sold.

Northern Trust first reported a position in HPTX in Q2 2013 and held it in 8 quarters. The position peaked at $6.97M in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • Northern Trust reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Northern Trust sold 151,944 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $6.97M.
  • Northern Trust first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • Northern Trust's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $6.97M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Northern Trust's 13F filing for Q2 2015, filed 13 Aug 2015.